| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.5% | +28% | $28,894,960 | +$6,937,840 | 1,516,000 | +32% | Armistice Capital, LLC | 31 Mar 2025 |
| BlackRock, Inc. | 7.7% | -22% | $26,340,596 | -$6,978,323 | 1,381,983 | -21% | BlackRock, Inc. | 31 Mar 2025 |
| STATE STREET CORP | 6% | $45,645,858 | 1,091,223 | STATE STREET CORPORATION | 31 Dec 2025 | |||
| Soleus Capital Master Fund, L.P. | 3.7% | -45% | $12,327,056 | -$8,850,562 | 658,145 | -42% | Soleus Capital Master Fund, L.P. | 30 Jun 2025 |
| MORGAN STANLEY | 0.7% | $3,297,817 | 116,406 | Morgan Stanley | 30 Sep 2025 | |||
| Invesco Ltd. | 0% | $122,918 | 6,449 | Invesco Ltd. | 31 Dec 2024 |
As of 31 Dec 2025, 181 institutional investors reported holding 16,003,642 shares of RIGEL PHARMACEUTICALS INC - COMMON STOCK (RIGL). This represents 88% of the company’s total 18,187,050 outstanding shares.
The largest institutional shareholders of RIGEL PHARMACEUTICALS INC - COMMON STOCK (RIGL) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.2% | 1,664,210 | -3.5% | 0% | $71,278,114 |
| STATE STREET CORP | 6% | 1,091,223 | +97% | 0% | $46,737,081 |
| VANGUARD GROUP INC | 5.7% | 1,038,408 | -0.45% | 0% | $44,475,015 |
| ARMISTICE CAPITAL, LLC | 4.6% | 836,000 | +15% | 0.88% | $35,805,880 |
| GOLDMAN SACHS GROUP INC | 3.7% | 671,878 | -8.8% | 0% | $28,776,535 |
| MARSHALL WACE, LLP | 3.4% | 613,600 | +2% | 0.03% | $26,280,489 |
| LSV ASSET MANAGEMENT | 3% | 544,282 | +391% | 0.05% | $23,312,000 |
| RENAISSANCE TECHNOLOGIES LLC | 3% | 539,009 | +14% | 0.04% | $23,085,755 |
| ACADIAN ASSET MANAGEMENT LLC | 2.7% | 493,604 | -28% | 0.03% | $21,132,000 |
| MILLENNIUM MANAGEMENT LLC | 2.4% | 431,460 | +310% | 0.01% | $18,479,432 |
| D. E. Shaw & Co., Inc. | 2.3% | 424,316 | +38% | 0.01% | $18,173,454 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 424,314 | +0.14% | 0% | $18,177,612 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.3% | 413,659 | +122% | 0.01% | $17,717,015 |
| Soleus Capital Management, L.P. | 1.6% | 300,034 | -9.1% | 0.55% | $12,850,456 |
| Qube Research & Technologies Ltd | 1.6% | 288,269 | -20% | 0.02% | $12,346,561 |
| Hillsdale Investment Management Inc. | 1.6% | 282,584 | -0.64% | 0.33% | $12,103,074 |
| DIMENSIONAL FUND ADVISORS LP | 1.5% | 276,812 | +32% | 0% | $11,855,857 |
| JANE STREET GROUP, LLC | 1.5% | 275,883 | -14% | 0.01% | $11,816,069 |
| TWO SIGMA INVESTMENTS, LP | 1.5% | 271,228 | +23% | 0.02% | $11,616,695 |
| Nuveen, LLC | 1.4% | 258,893 | +94% | 0% | $11,088,387 |
| AMERICAN CENTURY COMPANIES INC | 1.4% | 254,492 | 0.01% | $10,899,892 | |
| CM Management, LLC | 1.2% | 225,000 | 0% | 8.1% | $9,636,750 |
| GLOBEFLEX CAPITAL L P | 1.2% | 217,839 | +0.1% | 1.4% | $9,330,044 |
| Trexquant Investment LP | 1.1% | 197,148 | +18% | 0.08% | $8,443,849 |
| CITADEL ADVISORS LLC | 1% | 185,419 | +114% | 0.01% | $7,941,496 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 16,003,642 | $684,690,961 | +$62,177,393 | $42.83 | 181 |
| 2025 Q3 | 14,989,035 | $424,666,568 | +$32,448,563 | $28.33 | 164 |
| 2025 Q2 | 13,883,445 | $260,032,689 | +$336,299 | $18.73 | 121 |
| 2025 Q1 | 13,902,025 | $250,095,419 | +$32,047,743 | $17.99 | 118 |
| 2024 Q4 | 12,067,467 | $202,977,408 | +$2,514,731 | $16.82 | 114 |
| 2024 Q3 | 11,904,852 | $192,606,131 | +$27,253,219 | $16.18 | 87 |
| 2024 Q2 | 10,378,502 | $85,309,593 | +$85,148,446 | $8.22 | 80 |